1-5 of 5
Shreerang Sirdesai
Close
Sort by
Journal Articles

The Nature of High-Risk Defining Events in Follicular Lymphoma Determines Overall Survival

Joshua W.D. Tobin, Rakin Chowdhury, Ross Salvaris, Alison Griffin, Venkata Chikatamarla, Amanda Goh, Tsz Hung Tong, Callum Birks, Sanjiv Jain, Elizabeth Goodall, Shreerang Sirdesai, Thomas Trevis, Steinepreis Elizabeth, Yiyang Chen, Harrison Black, Glenn Broadby, Li Li, Naadir Gutta, Kirk Lachlan Morris, Tara Cochrane, Judith Trotman, Dipti Talaulikar, Jake Shortt, Georgina Hodges, Chan Y. Cheah, Allison A Barraclough, Kate Manos, Anna M. Johnston, Jane Royle, Patrizia Mondello, Stephen M Ansell, Greg Hapgood
Journal: Blood
Blood (2023) 142 (Supplement 1): 1671.
https://doi.org/10.1182/blood-2023-185879
Published: 2023
Journal Articles

Phase 1, First-in-Human Study of MEDI2228, a BCMA-Targeted ADC in Patients with Relapsed/Refractory Multiple Myeloma

Shaji K. Kumar, MD, Magdalini Migkou, Manisha Bhutani, MD, Andrew Spencer, Sikander Ailawadhi, Anna Kalff, MBBS (Hons) FRACP FRCPA, Farzana Walcott, Nabendu Pore, Diana Gibson, Fujun Wang, Lily Cheng, Ioannis Kagiampakis, Marna Williams, Krista Kinneer, Yu Jiang, Jeffrey Zonder, Jeremy Larsen, Shreerang Sirdesai, Andrew J. Yee, Meletios A Dimopoulos
Journal: Blood
Blood (2020) 136 (Supplement 1): 26–27.
https://doi.org/10.1182/blood-2020-136375
Published: 2020
Journal Articles

A Genotype-Phenotype Correlation of Haemophilia a in Victorian Patients with a Description of Novel Mutations

Shreerang Sirdesai, MBBS, FRACP, FRCPA, Kerryn Weekes, Asif Alam, Huyen A Tran, MBBS, MSc, FRACP, FRCPA, Christopher Barnes, MBBS, FRACP, FRCPA, Zane Kaplan, MBBS(Hons) BMedSc(Hons) PhD FRACP FRCPA
Journal: Blood
Blood (2018) 132 (Supplement 1): 2498.
https://doi.org/10.1182/blood-2018-99-112721
Published: 2018
Journal Articles

Phase 2 Trial of the Combination of Ixazomib, Thalidomide and Dexamethasone (ITD) in Relapsed/Refractory Myeloma: Planned Preliminary Analysis

Krystal Bergin, Flora Yuen, BBiomedSc, Craig Thomas Wallington-Beddoe, BSc, MBBS, PhD FRACP, FRCPA, Anna Kalff, MBBS, Shreerang Sirdesai, MBBS, FRACP, FRCPA, John Reynolds, PhD, Andrew Spencer, MBBS, MD FRACP, FRCPA
Journal: Blood
Blood (2018) 132 (Supplement 1): 3265.
https://doi.org/10.1182/blood-2018-99-118172
Published: 2018
Journal Articles

Preliminary Analysis of the Australasian Leukaemia and Lymphoma Group (ALLG) MM17 Trial: Response Adaptive Salvage Treatment with Carfilzomib-Thalidomide-Dexamethasone (KTd) for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients Failing Front-Line Bortezomib-Based Induction Therapy

Andrew Spencer, MBBS, FRACP, FRCPA, DM, Hang Quach, MD FRACP, FRCPA, MBBS, Noemi Horvath, MBBS FRACP FRCPA, Ian H. Kerridge, FRACP, FRCPA, MPhil, BA, Flora Yuen, BBiomedSc, Edwin Sze-Hung Lee, MD FRACP, FRCP, FRCPA, FRCPath, Edward S. Morris, BMBS, DM, Anna Kalff, MBBS, Krystal Bergin, Shreerang Sirdesai, MBBS, FRACP, FRCPA, Malgorzata Gorniak, BSc, Sridurga Mithraprabhu, PhD MSc, Tiffany Khong, BSc, PhD, John Reynolds, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3279.
https://doi.org/10.1182/blood-2018-99-113982
Published: 2018